Edesa Biotech, Inc.
EDSA
$2.43
$0.010.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -6.80% | 10.58% | -23.77% | -36.42% | -0.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.49% | -26.19% | 2.22% | -57.61% | -6.39% |
| Operating Income | 1.49% | 26.19% | -2.22% | 57.61% | 6.39% |
| Income Before Tax | -4.87% | 14.56% | 3.65% | 44.07% | 15.96% |
| Income Tax Expenses | -- | 0.00% | -- | -- | -- |
| Earnings from Continuing Operations | -4.87% | 14.55% | 3.65% | 44.07% | 15.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.87% | 14.55% | 3.65% | 44.07% | 15.96% |
| EBIT | 1.49% | 26.19% | -2.22% | 57.61% | 6.39% |
| EBITDA | 0.16% | 25.78% | -2.38% | 58.31% | 5.06% |
| EPS Basic | 51.89% | 48.58% | 9.90% | 47.88% | 23.55% |
| Normalized Basic EPS | 53.44% | 54.66% | 0.31% | 59.52% | 12.73% |
| EPS Diluted | 51.89% | 48.58% | 9.90% | 47.88% | 23.55% |
| Normalized Diluted EPS | 53.44% | 54.66% | 0.31% | 59.52% | 12.73% |
| Average Basic Shares Outstanding | 117.97% | 66.19% | 6.94% | 7.28% | 9.93% |
| Average Diluted Shares Outstanding | 117.97% | 66.19% | 6.94% | 7.28% | 9.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |